Shasun Pharmaceuticals has resumed the operations at Cuddalore plant on January 05, 2012. The operation has been disrupted due to severe cyclonic storm ‘Thane’ on December 30, 2011.
Shasun Pharmaceuticals manufactures active pharmaceutical ingredients (APIs), their intermediates and enteric coating excipients with a significant presence in some key generics. Shasun has created a strong product portfolio, building on its R & D Expertise, regulatory capabilities and multi scale production capacities. It is one of the largest producers of Ibuprofen worldwide.
